Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Ollmann Saphire

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
Cell Host & Microbe|April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other AntibodiesPhilipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
NPJ Vaccines|December 20, 2024
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 OmicronPaolla Beatriz Almeida Pinto, Julia Timis, Kantinan Chuensirikulchai, et al.
Journal of Virology|November 29, 2023
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H C Huntwork, Gillian Q Horn, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Frontiers in Immunology|March 26, 2024
Identification of mouse CD4<sup>+</sup> T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramersLaura Bricio-Moreno, Juliana Barreto de Albuquerque, Jake M Neary, et al.
Plos Neglected Tropical Diseases|March 7, 2022
Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the CongoKelly C L Shaffer, Sean Hui, Anna Bratcher, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Ebiomedicine|February 28, 2025
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityFernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionJennifer M Dan, Jose Mateus, Yu Kato, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
Cell Host & Microbe|April 23, 2020
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other AntibodiesPhilipp A Ilinykh, Kai Huang, Rodrigo I Santos, et al.
NPJ Vaccines|December 20, 2024
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 OmicronPaolla Beatriz Almeida Pinto, Julia Timis, Kantinan Chuensirikulchai, et al.
Journal of Virology|November 29, 2023
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variantsKan Li, Richard H C Huntwork, Gillian Q Horn, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Frontiers in Immunology|March 26, 2024
Identification of mouse CD4<sup>+</sup> T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramersLaura Bricio-Moreno, Juliana Barreto de Albuquerque, Jake M Neary, et al.
Plos Neglected Tropical Diseases|March 7, 2022
Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the CongoKelly C L Shaffer, Sean Hui, Anna Bratcher, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Ebiomedicine|February 28, 2025
A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityFernanda Ana-Sosa-Batiz, Shailendra Kumar Verma, Norazizah Shafee, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionJennifer M Dan, Jose Mateus, Yu Kato, et al.
Pageof 22